Sunday March 21, 2021
Sold to neighbors
South Africa parts with Astrazeneca cans
South Africa has bought a lot of vaccine but does not use it. According to a study, the Astrazeneca vaccine should only provide limited protection against the prevailing corona variant, which is why it is now being sold to neighboring countries.
South Africa, hard hit by the corona pandemic, has sold its supply of one million doses of the Astrazeneca corona vaccine to its neighbors. The units should go to 14 other African countries, said Health Minister Zweli Mkhize. In the past few weeks, his ministry had ensured that the buyer states proposed by the African Union (AU) were able to organize a vaccination campaign. The money for the purchase of the vaccine has already been paid.
South Africa renounces the use of its Astrazeneca cans and postponed its vaccination campaign with the vaccine at the beginning of February. The government pointed out that, according to a study, it offers limited protection against the virus variant that is rampant in South Africa. Instead of Astrazeneca, vaccines from Johnson & Johnson and Biontech / Pfizer are now to be used in the country.
Because of the more contagious virus variant, the German federal government classified the Cape State as a corona risk area with particularly dangerous virus mutations at the beginning of February. However, the numbers in South Africa have now fallen so sharply that the lowest level of the five-part corona alarm system has been in place there since March 1.
In the African country most severely affected, more than 1.5 million infections have been registered since the beginning of the pandemic, and more than 52,000 people have died as a result. Africa represents a total of 3.5 percent of the corona infections discovered worldwide. According to official figures, around 107,000 people have died across the continent as a result of a Covid 19 infection.